We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » STRENGHTHEN BIOSHIELD I, BUT NIX S. 666, GPhA TELLS CONGRESS
STRENGHTHEN BIOSHIELD I, BUT NIX S. 666, GPhA TELLS CONGRESS
November 2, 2004
The nation’s generic firms and prescription purchasers are in for a bleak future if current and proposed Bioshield legislation is not handled properly, the Generic Pharmaceutical Association (GPhA) warned.